Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2025-03-10 00:00:00 ET · period of report 2025-03-07 · accession 0000950170-25-036693 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-10 | 2025-03-07 | SRPT | Rothfuss Cristin | EVP, GC | F - Tax | $103.70 | -1,478 | 11.8K | -11% | -$153.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-07 | F | D | 1,131 | $103.70 | 12,194 | D | — | — | (F1) Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 6, 2023. |
| 2 | Common | Common Stock | 2025-03-07 | F | D | 347 | $103.70 | 11,847 | D | — | — | (F2) Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023. |